A new study suggests that consuming sucralose may hinder the effectiveness of cancer immunotherapy. The sweetener, commonly used as a low-calorie alternative to sugar, has been shown to reduce the immune system’s ability to detect and destroy cancer cells. According to Dr. Abigail Overacre-Delgoffe at the University of Pittsburgh, immunotherapy is a crucial treatment option for many cancers but only works for a minority of patients. The findings highlight the need for further research into the potential interactions between sucralose and cancer treatments.
Source: https://www.newscientist.com/article/2490684-common-artificial-sweetener-may-interfere-with-cancer-treatments